MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics

Abstract

The volume of point of care (POC) testing continues to grow steadily due to the increased availability of easy-to-use devices, thus making it possible to deliver less costly care closer to the patient site in a shorter time relative to the central laboratory services. A novel class of molecules called microRNAs have recently gained attention in healthcare management for their potential as biomarkers for human diseases. The increasing interest of miRNAs in clinical practice has led to an unmet need for assays that can rapidly and accurately measure miRNAs at the POC. However, the most widely used methods for analyzing miRNAs, including Northern blot-based platforms, in situ hybridization, reverse transcription qPCR, microarray, and next-generation sequencing, are still far from being used as ideal POC diagnostic tools, due to considerable time, expertize required for sample preparation, and in terms of miniaturizations making them suitable platforms for centralized labs. In this review, we highlight various existing and upcoming technologies for miRNA amplification and detection with a particular emphasis on the POC testing industries. The review summarizes different miRNA targets and signals amplification-based assays, from conventional methods to alternative technologies, such as isothermal amplification, paper-based, oligonucleotide-templated reaction, nanobead-based, electrochemical signalingbased, and microfluidic chip-based strategies. Based on critical analysis of these technologies, the possibilities and feasibilities for further development of POC testing for miRNA diagnostics are addressed and discussed.

Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study

“…We speculate that future FUO research may be leaving the twilight zone as diagnostic microcellular research technologies emerge from the laboratory to point-of-care rapid diagnostic kits. We await further advances in diagnostic artificial intelligence to expose FUO cause in more cases 41 42…”

miRNAs in the Diagnosis and Prognosis of Skin Cancer

“…This step is followed by the absolute quantification of small miRNA panels. Although it is easy to be included into routine measurement workflow with robust automation, RT-PCR cannot be enrolled for new miRNA species detection; moreover, the reaction conditions may differ according to each miRNA due to sequence-specific differences in primer annealing (Dave et al, 2019). Specific miRNAs are altered in solid tumors, including melanoma, and hence, RT-PCR is very useful in detecting such modified expressions.…”

PNA-Based MicroRNA Detection Methodologies

“…This correlation between the dysregulation of specific miR sequences and the onset of specific pathologies has spurred the development of new methodologies for the precise quantification of these shorts sequences, with some of these methods already available on the market [25][26][27]. The use of DNA microarrays is a well-established method for low-cost high-throughput relative quantification.…”